Letourneau JM

No ORCID on file · 3 papers in corpus · active 2022-2025
2025
Autoimmune Disease is Increased in Women With Primary Ovarian Insufficiency.
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgae828

ContextAutoimmune disease is common in women with primary ovarian insufficiency (POI), and the genetic etiology of autoimmune disease suggests that it could be hereditary in families of women with POI.ObjectiveWe hypothesized that a subset …

2022
Effect of chemotherapy on the uterus of young adult cancer survivors.
F&S reports ·doi:10.1016/j.xfre.2022.05.008

ObjectiveTo investigate the impact of chemotherapy on the uterus.DesignCross-sectional pilot study.SettingSingle university fertility clinic.PatientsTwelve patients with a history of alkylating agent chemotherapy exposure after Hodgkin lymp…

2022
Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen.
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02626-6

BackgroundIn this secondary analysis of the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) trial, we aimed to investigate if concurrent administration of letrozole vs. tamoxifen vs. no added treatment affects hormonal compositi…